Co-Investment vs Direct Investment for LPs

For LPs comparing co-investment vs direct investment, the practical difference is who owns the work. A co-investment puts an LP’s capital into one named company alongside the GP that sourced, underwrote and negotiated the transaction, usually through a special purpose vehicle, and usually on reduced or waived fee and carry terms. A self-led direct investment puts the same single-name risk on the LP’s balance sheet, but the LP owns origination, diligence, financing, documentation, governance and exit. The fee saving is easy to see. The harder task is judging, in the two or three weeks a sponsor may allow, why that allocation was available at all.

When each route fits

Co-investment is the practical route for most LPs that want deal-specific exposure without building a sponsor’s operating capability. It gives access to a GP’s sourcing engine and diligence work while reducing the management fee and carry drag that applies to the blind-pool commitment.

Direct investment is right only when the LP can act like a sponsor: originate, underwrite, negotiate security and governance terms, monitor the asset and drive the exit. Absent that capability, a direct stake becomes a control claim the LP cannot enforce and a monitoring burden it cannot carry.

Terminology to fix before comparing structures

“Direct co-investment” is used inconsistently across the market. Some practitioners mean a deal-by-deal investment alongside a lead sponsor. Others mean investing straight into the target company rather than through the sponsor’s SPV.

Both meanings appear in practitioner literature, so the drafting matters more than the label. An LP that invests through a co-investment SPV holds an interest in the vehicle, not in the company. An LP that invests directly into the target sits on the cap table and can negotiate minority protections, information rights, tag-along rights and, in some structures, registration rights. Practitioner material on lower-middle-market deals suggests direct target-level positions give more scope for those protections, although that evidence rests on a limited sample.

Neither route is a blind-pool fund commitment, where the GP selects future assets after the capital is committed. Neither is automatically fee-free.

Workstream ownership from origination to exit

The execution sequence is the same in both routes, but the owner of each step changes the risk the LP is taking. In co-investment, the LP challenges a GP-led process. In self-led direct investment, the LP builds and controls that process itself.

1. Opportunity identification. The GP sends the teaser and initial deck, or the LP originates through its own network.
2. Preliminary screen. The co-investor tests sector fit, sponsor track record and allocation size. The direct investor tests the same points plus seller motivation and process dynamics.
3. Investment committee go or no-go. Co-investment IC papers are often due within days. Direct IC timing follows the LP’s own process, but the paper has to be built from scratch.
4. Diligence. The co-investor reads the sponsor’s commercial, financial, tax and legal reports and challenges the assumptions. The direct investor commissions and pays for the due diligence work.
5. Financing review. The co-investor reviews debt quantum, pricing and covenants already agreed by the sponsor. The direct investor negotiates with lenders itself.
6. Documentation. SPV operating agreement, subscription documents and side letter, versus a full shareholders’ agreement and equity purchase documentation.
7. Closing, monitoring, follow-on and exit. The co-investor takes GP reporting and follows the GP’s exit. The direct investor builds reporting, manages the board seat and runs the sale process.

Co-underwriting, where the LP commits before the sponsor signs, collapses steps two to five into a window most LP investment committees are not built for. It requires pre-agreed approval thresholds and a standing playbook, rather than a bespoke process invented for each deal.

Fee savings and replacement costs

Buyout fund economics are commonly described using 2 and 20 shorthand, although actual terms vary widely. Co-investments are frequently offered on reduced or no-fee, no-carry terms, while dedicated co-investment funds sit somewhere between the two, with lower management fees and carry than primary buyout funds. Treat any specific fee figure as directional.

Removing fee and carry drag improves net returns on the same gross outcome. Because capital goes into an identified asset rather than an undrawn commitment, co-investment can also shorten the early negative return period known as the J-curve. A BlackRock white paper from 2019 estimated that a 20 to 30 per cent co-investment allocation could pull the J-curve forward by 12 to 18 months. That estimate came from internal simulations and is dated, so it should be treated as commentary rather than a planning input.

Direct investing removes fund-level fees entirely and replaces them with a cost base: investment staff, outside counsel, accounting and tax advisers, commercial consultants, financing advisers and ongoing monitoring. On a two or three deal per year programme, those costs can exceed the fee saving. The comparison that counts is net return after all internal and external costs, not the headline fee line.

Evidence on co-investment outperformance is mixed. Some LP surveys report better results than fund commitments, and one widely cited pension comparison shows a materially higher co-investment IRR, but those figures are frequently secondary citations and should be verified before they drive an allocation decision. Practitioner commentary also notes that real-world co-investment results have sometimes been only similar to fund returns.

Why the allocation exists

This underwriting question separates competent co-investors from passengers. A discounted fee schedule is attractive only if the LP understands the sponsor’s reason for syndicating the equity.

GPs syndicate equity for structural reasons. Fund concentration limits in the limited partnership agreement cap how much of a single fund can go into one company. Take a hypothetical 750 million dollar fund facing a platform acquisition too large for that cap: the GP invests to its limit, arranges debt, and offers the residual equity to LPs. That is a clean rationale and says nothing negative about the asset.

Other rationales are less clean. The GP may be managing its own concentration risk, rewarding LPs it wants back in the next fund, or filling a gap created because other LPs already passed. Adverse selection is a risk in deal-by-deal syndication, and the compressed timeline reduces the LP’s ability to test the sponsor’s case.

Three diligence questions apply to every offered allocation:

• Which other LPs were offered the deal, and did any decline?
• Is the co-investment sized by the fund’s concentration cap, or by the equity the sponsor is unwilling to hold?
• Does the LP have access to the underlying diligence reports and management, or only the sponsor’s summary deck?

Run the downside case independently. Sensitise entry multiple, exit multiple, leverage, EBITDA growth, margin expansion, capex and working capital. If the equity story only works at the sponsor’s exit multiple, the LP is buying multiple expansion rather than operating improvement.

Deal points that change the economics

Fee and carry terms get the attention. In practice, the surrounding rights can change the economics just as much:

• Broken-deal expenses. Who pays legal and adviser costs if the transaction fails before signing.
• Pro-rata and follow-on rights. Whether the LP can participate in later equity rounds, and whether it can be diluted if it declines.
• Information rights. Frequency and content of financial reporting, and access to board materials.
• Tag-along and transfer rights. Whether the LP exits alongside the sponsor and on what terms, and whether it can transfer its interest.
• Conflict provisions. How the GP resolves conflicts between the main fund and the co-investment vehicle, particularly on follow-on funding and exit timing.

An LP that accepts a no-fee co-investment with no follow-on right and no exit protection has traded a known cost for an unknown one. The same concern applies to direct target-level positions, where minority protections and tag-along rights need to be negotiated before the LP relies on them.

Portfolio construction

Both routes produce single-name exposure, and deal-level private equity returns are heavily skewed. A handful of co-investments does not diversify anything.

Co-investment programmes scale across sponsors, sectors and vintages if the LP has the access to build a meaningful number of positions. Direct programmes rarely do, because each position consumes governance capacity. Track co-investments as individual company exposures in portfolio reviews, grouped by GP, sector, vintage, leverage level and value creation thesis, and never as an extension of the fund allocation.

Choosing for a live deal

Take the co-investment when the sponsor is a manager the LP already underwrites, the diligence access is genuine rather than a summary deck, the timeline fits the LP’s IC process, and the LP can run its own downside case. Accept minority rights honestly and negotiate information, follow-on and tag-along terms rather than fee terms alone.

Go direct when the LP has a sourcing edge in the sector, a team that can run diligence and financing, the governance capacity to take a board seat, and an exit view it can act on. Anything less and the LP is paying for control it will not exercise.

Pass, or route capital through a dedicated co-investment fund, when the LP lacks deal flow, staff or decision speed. Paying a co-investment fund a lower fee and carry than a primary buyout fund is a defensible outcome. Accepting single-asset risk the LP cannot underwrite is not.

Conclusion

The lowest stated fee is the weakest basis for this decision. A co-investment with no management fee and no carry still concentrates capital in one company selected by someone else, on a timetable set by someone else, for reasons the LP may never fully see.

The condition for success is unglamorous: an LP that can form an independent view of the asset, negotiate rights proportionate to the role it is actually playing, and hold enough positions for deal-level skew to work in its favour. An LP that cannot do all three is better served by the blind-pool commitment it already pays for.

P.S. If you are underwriting co-investments on a sponsor’s timetable, check out our Premium Resources for LBO and fund models, PE and LP databases and more tools to help you advance your career.

Sources

• Benefits and Challenges of Co-Investments for Private Equity LPs – Chronograph
• Understanding direct and co-investments in private markets
• LP Co-Investments: Benefits, Risks, and Deal Points
• Co-Investments in Private Equity and Venture Capital – Carta
• Private Equity Co-Investments: Deals, Industry, Careers
• The Advantages of Co-Investments
• The Rise of Co-Investments, and Why LPs Want More